arrow
S

Salvador Martín-Algarra

clínica universidad de navarra
H指数:39
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer

传统类型1 DC密度与多种癌症类型的检查点抑制剂反应相关

2026-05-011
PRE
Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801

标题:西班牙免疫治疗和靶向治疗时代未知原发灶黑色素瘤的特征:前瞻性真实世界研究GEM 1801的结果

2025-12-200
PRE
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study

西班牙晚期黏膜黑色素瘤患者的治疗效果:来自真实世界GEM1801研究的结果

2025-12-010
PRE
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801

应答率和长期生存率在晚期黑色素瘤患者中的表现:来自前瞻性队列研究gem-1801的数据

2025-11-280
OAAI
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry

肢端黑色素瘤患者中基于抗PD-1抗体免疫疗法的效果不佳:西班牙黑色素瘤组(GEM)登记研究的结果

2025-08-210
PRE
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: results from the real-world Spanish Melanoma Registry (GEM-1801)

复发治疗和再挑战使用BRAF/MEK抑制剂在转移性黑色素瘤患者中的效果:来自西班牙黑色素瘤登记系统(GEM-1801)的真实世界结果

2025-07-270
PRE
Characterization of melanoma of unknown primary in the era of immunotherapy and targeted therapy in Spain: Results from the prospective real-world study GEM 1801
2023-10-010
PRE
Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study
2023-09-011
OAAI
Demography and clinical outcomes of adjuvant therapy in Spain: Results from GEM 1801 study
2022-09-010
PRE
Elderly patients (pts) with advanced melanoma: Results from the prospective real-world study GEM1801
2022-09-010
OAAI
Survival of patients with advanced melanoma according to first-line treatment and key prognostic factors: Real-world data from GEM1801 study
2021-09-011
OAAI
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors
2020-10-1458
PREAI
y SAFETY & EFFICACY OF LIFILEUCEL (LN-144) TUMOR INFILTRATING LYMPHOCYTE THERAPY IN METASTATIC MELANOMA PATIENTS AFTER PROGRESSION ON MULTIPLE THERAPIES - INDEPENDENT REVIEW COMMITTEE DATA UPDATE
2020-04-153
OAAI
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
2018-10-0178
OAAI
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients

晚期癌症患者的联合免疫疗法,包括肿瘤内多聚ICLC,树突状细胞疫苗接种和放疗

2018-05-01116
OAAI
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

干扰素 γ,非小细胞肺癌和黑色素瘤患者对免疫检查点阻断反应的重要标志物

2018-01-18180
OAAI